Board of Directors

At Somahlution, we are serious about surrounding ourselves with intelligent, experienced professionals who can help us grow our business and improve our processes. Strong corporate governance is essential for a successful business, and our board members ensure Somahlution operates with integrity and accountability. We seek to build and maintain a Board of Directors with a wide range of experiences, competencies and perspectives and who help direct strategy, and can help us adapt to growing and changing markets, and geographic and regulatory environments.

Vithalbhai Dhaduk, M.D. – Chairman

Vithalbhai Dhaduk, M.D. - Chairman

Board of Directors

Dr. Dhaduk is the Chairman of the Board of Directors of Somahlution. He is an accomplished serial entrepreneur and serves as Chairman of several biotechnology companies, many of which he cofounded, including, Apicore Pharma, Synerex Pharmaceuticals, Nuron Biotech and Core Pharma.<br><br>Dr. Dhaduk provides leadership and guidance in the areas of product development, marketing, partner relationships, financial matters, and corporate governance. His extensive background in biotechnology and the pharmaceutical industry is an important asset to Somahlution’s development and business plans.<br><br>Dr. Dhaduk is an actively practicing neurologist and is currently the Chief of Neurology at the Community Medical Center in Scranton, PA and a Fellow of the American Academy of Neurology. His post-graduate medical training was conducted at the B.J. Medical College in Ahmedabad, India and at the Medical College of Pennsylvania in Philadelphia, where he also served as the Chief Resident in Neurology.<br><br>Dr. Dhaduk has received numerous honors in medical practice. Most notably, he received the David Dunn Memorial Award in 1986 and 1987 for Outstanding Teaching and Study of Neurology at the Medical College of Pennsylvania. He also serves on the board of several professional organizations in neurology and medicine. He is the chair of CARITAS International Trading and CARITAS Hospitality, LLC, on the advisory boards of Hope Medical Institute, Lublin College of Medicine, Poland, as well as the Lupus Foundation of Pennsylvania. He has been awarded the National Leadership Award serving as honorary co-chairman of the Physician’s Advisory Board, Pennsylvania.

View More
Satish Chandran, Ph.D. – Chief Executive Officer

Satish Chandran, Ph.D. - Chief Executive Officer

Board of Directors, Executive Management Team

Dr. Chandran co-founded Somahlution with Chairman Dr. Dhaduk, and has served as the Company’s Chief Executive and a member of the Board of Directors since inception in 2010. He is a distinguished biotechnology veteran with nearly 25 years of leadership positions.<br><br>Until 2012, Dr. Chandran was the Director of the Center of Excellence for Biopharmaceutical Research & Development and Professor of Pharmaceutics at North Dakota State University. Prior to that, he was the Chief Technology Officer at the BioTx Division of Pfizer, in Cambridge. Previous to Pfizer, he was a Professor at the Institute for Hepatitis and Virus Research in Doylestown, PA, and was the Chief Operating Officer and Chief Scientific Officer at Nucleonics, the first RNAi-based company, in Horsham PA, a company that he cofounded while on the faculty at Thomas Jefferson University’s Biochemistry Department.<br><br>Prior to founding Nucleonics, Dr. Chandran led the DNA Vaccine Division of Wyeth-Lederle Vaccines following its 1998 acquisition of Apollon, Inc., a biotech company in Malvern, PA, focused on advancing DNA vaccine-based product candidates for infectious diseases and cancer.<br><br>Dr. Chandran received his Ph.D. from Memorial University in Newfoundland, Canada and completed a post-doctoral fellowship at Fox Chase Cancer Center in Philadelphia. He is a strategic consultant and a member of the Board of Directors for several emerging and established biotechnology companies.

View More
Catherine Pachuk, Ph.D. – Chief Scientific Officer

Catherine Pachuk, Ph.D. - Chief Scientific Officer

Board of Directors, Executive Management Team

Dr. Pachuk joined Somahlution as its Chief Scientific Officer in August 2011 and is a member of the Company’s Board of Directors. She has twenty years of R&D leadership experience in the pharmaceutical and biotech sectors with expertise in drugs, biologics and vaccine development. She was involved in advancing multiple product candidates into the clinic.<br><br>Dr. Pachuk began her biotech career with Apollon, Inc. developing oligonucleotide-based therapeutics, and subsequently DNA-based vaccines for both viral and oncology indications. Following the acquisition of Apollon, Inc. by Wyeth-Lederle Vaccines in 1998 she continued to direct vaccine programs which resulted in several products being advanced into the clinic.<br><br>In 2001 she co-founded Nucleonics, a biotech focused on the development of RNAi-based therapeutics. Until April of 2008, she was VP of Preclinical Research. Since then and until joining Somahlution, Dr. Pachuk has lead biology efforts for Pfizer’s oligonucleotide therapeutic programs in the areas of oncology and metabolic disease and was a member of the Executive Leadership Team. <br><br>Dr. Pachuk received her Ph.D. in molecular virology from the University of Pennsylvania and completed a post-doctoral fellowship at SmithKline Beecham.

View More

Executive Management Team

We invest a lot of time and effort in finding people with the right mix of experiences, diversity and backgrounds who will work together to make the best decisions for the Company and drive results. We believe in operating our business at the highest ethical standards, and our values of honesty, fairness and objectivity guide our business and ensure we maintain the trust of our constituents. Somahlution has assembled a team of experienced executives, employees, advisors and consultants to advance its mission.

Satish Chandran, Ph.D. – Chief Executive Officer

Satish Chandran, Ph.D. - Chief Executive Officer

Board of Directors, Executive Management Team

Dr. Chandran co-founded Somahlution with Chairman Dr. Dhaduk, and has served as the Company’s Chief Executive and a member of the Board of Directors since inception in 2010. He is a distinguished biotechnology veteran with nearly 25 years of leadership positions.<br><br>Until 2012, Dr. Chandran was the Director of the Center of Excellence for Biopharmaceutical Research & Development and Professor of Pharmaceutics at North Dakota State University. Prior to that, he was the Chief Technology Officer at the BioTx Division of Pfizer, in Cambridge. Previous to Pfizer, he was a Professor at the Institute for Hepatitis and Virus Research in Doylestown, PA, and was the Chief Operating Officer and Chief Scientific Officer at Nucleonics, the first RNAi-based company, in Horsham PA, a company that he cofounded while on the faculty at Thomas Jefferson University’s Biochemistry Department.<br><br>Prior to founding Nucleonics, Dr. Chandran led the DNA Vaccine Division of Wyeth-Lederle Vaccines following its 1998 acquisition of Apollon, Inc., a biotech company in Malvern, PA, focused on advancing DNA vaccine-based product candidates for infectious diseases and cancer.<br><br>Dr. Chandran received his Ph.D. from Memorial University in Newfoundland, Canada and completed a post-doctoral fellowship at Fox Chase Cancer Center in Philadelphia. He is a strategic consultant and a member of the Board of Directors for several emerging and established biotechnology companies.

View More
Catherine Pachuk, Ph.D. – Chief Scientific Officer

Catherine Pachuk, Ph.D. - Chief Scientific Officer

Board of Directors, Executive Management Team

Dr. Pachuk joined Somahlution as its Chief Scientific Officer in August 2011 and is a member of the Company’s Board of Directors. She has twenty years of R&D leadership experience in the pharmaceutical and biotech sectors with expertise in drugs, biologics and vaccine development. She was involved in advancing multiple product candidates into the clinic.<br><br>Dr. Pachuk began her biotech career with Apollon, Inc. developing oligonucleotide-based therapeutics, and subsequently DNA-based vaccines for both viral and oncology indications. Following the acquisition of Apollon, Inc. by Wyeth-Lederle Vaccines in 1998 she continued to direct vaccine programs which resulted in several products being advanced into the clinic.<br><br>In 2001 she co-founded Nucleonics, a biotech focused on the development of RNAi-based therapeutics. Until April of 2008, she was VP of Preclinical Research. Since then and until joining Somahlution, Dr. Pachuk has lead biology efforts for Pfizer’s oligonucleotide therapeutic programs in the areas of oncology and metabolic disease and was a member of the Executive Leadership Team. <br><br>Dr. Pachuk received her Ph.D. in molecular virology from the University of Pennsylvania and completed a post-doctoral fellowship at SmithKline Beecham.

View More
José E. Cabrera, BA – Vice President, Regulatory Affairs & Quality Affairs, Management Representative

José E. Cabrera, BA - Vice President, Regulatory Affairs & Quality Affairs, Management Representative

Executive Management Team

Mr. Cabrera is Vice President of Regulatory Affairs & Quality Affairs and is Somahlution's Management Representative. He joined Somahlution in March of 2014 and has been developing global regulatory affairs strategies and Quality Systems compliant with US FDA and European regulations.<br><br>Mr. Cabrera served in the U.S. Army as a Combat Medic with the 101st Airborne Division in Ft. Campbell KY. After graduating from the University of Dallas with a B.A. in Cell Biology in 1994, he went on to teach science courses in high school and college. Since 2001, Jose managed several clinical studies that involved Class III implantable medical devices and prepared two PMA submissions for a Dutch ophthalmology device company entering into the US market.<br><br>After receiving FDA approval for the new technology devices, Mr. Cabrera manage international regulatory affairs and act as Quality System liaison for all of Bausch + Lomb’s businesses in Latin America. The portfolio included pharmaceuticals, medical devices and nutritional products. He provided regulatory affairs support for manufacturing facility in Porto Alegre Brazil. He also worked for BIOMET in Palm Beach Gardens as the Global Regulatory Affairs Lead where he was responsible for new product registrations, global surveillance, and medical device reporting. Most recently, Mr. Cabrera worked as a consultant to small and large organizations providing support in authoring clinical, quality and regulatory procedures and policies and supporting ISO 13485 implementation and CE marking of medical devices for Europe.

View More
Megan Johnson- Vice President, Chief Financial Officer

Megan Johnson- Vice President, Chief Financial Officer

Executive Management Team

Ms. Johnson has been with Somahlution since August 2014. She has over 20 years of experience in accounting and finance and 17 years in the medical device industry.<br><br>She received her BS degree in Accounting from Florida State University and began her career with Centex Homes in South Florida, holding a position of Assistant Controller.<br><br>She then joined Biomet 3i in 1998, where she was responsible for the global financial dental organization with a heavy emphasize on ERP implementation, financial reporting and process improvement.

View More
Mary O’Brien – Senior Director, Procurement  and Supply Chain

Mary O’Brien - Senior Director, Procurement and Supply Chain

Executive Management Team

Mary joined Somahlution in September 2014. She has over 26 years of experience in operations, supply chain and accounting, with the most recent seven years working in the pharma industry.<br><br>Mary received an AA Degree in Accounting at Bucks County Community College, Newtown, PA and Continuing Education Credits in Accounting and Information Technology at La Salle University, Philadelphia, PA.<br><br>She began her career with Modern Mailers, Inc. as a System’s Analyst and Programmer, designing accounting and supply systems in both Cobol and RPG languages. She successfully implemented the operations and supply chains for the Publishing Industry and Pharmaceutical Industry for companies such as Associates in Medical Marketing, Synerx, Mylan and Apicore.

View More
Karen E. Gerard – Director, Human Resources, Facilities and IT

Karen E. Gerard - Director, Human Resources, Facilities and IT

Executive Management Team

Ms. Gerard has been with Somahlution since July of 2012. She has over 20 years of experience in management and over 10 years of experience in human resources.<br><br>Karen received her A.S. in Science from University of Maine at Presque Isle and attended the University of Southern Maine Nursing Program. <br><br>Karen began her career with UNUM, a market leader in making disability, life, accident and critical illness insurance accessible in the workplace, working in the Medical Benefit department for four years and spent six years managing the Life & AD&D Benefit department.<br><br>Karen was Loss Mitigation Manager for Morgan Stanley’s Residential Mortgage Business, which was responsible for monitoring vendor performance, mitigating and identifying risk and negotiating with mortgage originators on delinquent loans with counterparties in the U.S.

View More